PortfoliosLab logoPortfoliosLab logo
P3 Health Partners Inc (PIIIW)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date
Apr 7, 2021

Highlights

Market Cap
$42.48K
Enterprise Value
$76.58M
EPS (TTM)
-$52.47
Total Revenue (TTM)
$1.46B
Gross Profit (TTM)
$325.47M
EBITDA (TTM)
-$213.14M
Year Range
$0.00 - $0.02
ROA (TTM)
-36.58%
ROE (TTM)
154.75%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


P3 Health Partners Inc

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in P3 Health Partners Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

P3 Health Partners Inc (PIIIW) has returned -41.00% so far this year and -50.83% over the past 12 months.


P3 Health Partners Inc

1D
0.00%
1M
-9.23%
YTD
-41.00%
6M
-36.56%
1Y
-50.83%
3Y*
-58.08%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Apr 7, 2021, PIIIW's average daily return is +0.49%, while the average monthly return is +1.42%. At this rate, your investment would double in approximately 4.1 years.

Historically, 35% of months were positive and 65% were negative. The best month was May 2023 with a return of +336.6%, while the worst month was Dec 2022 at -73.8%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 5 months.

On a daily basis, PIIIW closed higher 30% of trading days. The best single day was Dec 14, 2023 with a return of +125.0%, while the worst single day was Dec 13, 2023 at -75.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-26.00%-12.16%-9.23%-41.00%
202568.07%-22.00%-23.08%-1.67%-13.56%9.80%3.57%9.49%-26.78%8.60%-8.91%8.70%-15.97%
2024-50.57%98.26%-19.57%-21.43%-29.12%93.47%-43.93%-49.08%56.63%-48.24%-47.57%10.19%-88.65%
202317.86%-28.73%-31.89%-11.36%336.62%-22.58%-25.00%38.94%-32.02%-10.29%-17.70%-16.49%-25.14%
2022-26.70%16.49%77.36%-24.21%-40.23%-30.57%42.00%5.65%-1.77%-17.20%-12.31%-73.83%-86.67%
2021-2.64%43.82%32.38%-10.07%-12.00%-19.98%42.01%8.00%-22.22%40.02%

Benchmark Metrics

P3 Health Partners Inc has an annualized alpha of 215.59%, beta of 0.70, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since April 08, 2021.

  • This stock participated in 240.03% of S&P 500 Index downside but only -33.83% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.70 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
215.59%
Beta
0.70
0.00
Upside Capture
-33.83%
Downside Capture
240.03%

Return for Risk

Risk / Return Rank

PIIIW ranks 29 for risk / return — below 29% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


PIIIW Risk / Return Rank: 2929
Overall Rank
PIIIW Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
PIIIW Sortino Ratio Rank: 4545
Sortino Ratio Rank
PIIIW Omega Ratio Rank: 4545
Omega Ratio Rank
PIIIW Calmar Ratio Rank: 1515
Calmar Ratio Rank
PIIIW Martin Ratio Rank: 1313
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for P3 Health Partners Inc (PIIIW) and compare them to a chosen benchmark (S&P 500 Index).


PIIIWBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.30

0.90

-1.20

Sortino ratio

Return per unit of downside risk

0.63

1.39

-0.76

Omega ratio

Gain probability vs. loss probability

1.08

1.21

-0.13

Calmar ratio

Return relative to maximum drawdown

-0.74

1.40

-2.14

Martin ratio

Return relative to average drawdown

-1.35

6.61

-7.96

Explore PIIIW risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


P3 Health Partners Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the P3 Health Partners Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the P3 Health Partners Inc was 99.72%, occurring on Feb 24, 2026. The portfolio has not yet recovered.

The current P3 Health Partners Inc drawdown is 99.65%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.72%Apr 4, 2022975Feb 24, 2026
-67.3%Nov 15, 202145Jan 19, 202244Mar 23, 202289
-42.3%Jul 16, 202155Oct 1, 202125Nov 5, 202180
-21.74%Apr 29, 20211Apr 29, 202110May 13, 202111
-19.32%Apr 16, 20211Apr 16, 20218Apr 28, 20219

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of P3 Health Partners Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how P3 Health Partners Inc is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for PIIIW relative to other companies in the Medical Care Facilities industry. Currently, PIIIW has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items